Patent · US Active

Uses of DPP IV inhibitors

US11291668B2 · kind B2 · utility

0Cited by

163References

1Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Klaus Dugi · Dresden, DE
Frank Himmelsbach · Mittelbiberach, DE
Michael Mark · Biberach an der Riß, DE

Key dates

Filing date	Mar 25, 2020
Grant date	Apr 5, 2022
Priority date	—
Expiry date	Mar 25, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.